Effectiveness of successive booster vaccine doses against SARS-CoV-2 related mortality in residents of long-term care facilities in the VIVALDI study.

Oliver T StirrupMadhumita ShrotriNatalie L AdamsMaria KrutikovBorscha AzmiIgor MonakhovGokhan TutPaul MossAndrew HaywardAndrew CopasLaura Shallcross

Published in: Age and ageing (2023)

Successive booster vaccination doses provide additional short-term protection against SARS-CoV-2 related mortality amongst older LTCF residents. However, we did not find evidence of a longer-term reduction in risk beyond that provided by initial booster vaccination.

Keyphrases

sars cov
long term care
cardiovascular events
respiratory syndrome coronavirus
randomized controlled trial
risk factors
type diabetes
middle aged
cardiovascular disease
coronary artery disease
preterm birth